Paxlovid rebound patient did not show drug resistance or impaired immunity — ScienceDaily - Verve Times
6/21/2022 12:00:00 AM2 years 10 months ago
by Addrew Shawn
by Addrew Shawn
Paxlovid is the leading oral medication for preventing severe cases of COVID-19 in high-risk individuals. However, symptoms returned in some patients after treatment was completed, prompting the Centers for Disease Control and Prevention (CDC) to iss
Paxlovid is the leading oral medication for preventing severe cases of COVID-19 in high-risk individuals. However, symptoms returned in some patients after treatment was completed, prompting the Cent… [+3762 chars]
full article...